Judilyn Fuentes‐Duculan

Author

Also Known As

Fuentes-Duculan, J, J Fuentes-Duculan, J. Fuentes-Duculan, J. Fuentes‐Duculan, Judilyn Fuentes Duculan, Judilyn Fuentes-Duculan, Judilyn Fuentes‐Duculan

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

Rockefeller University Icahn School of Medicine at Mount Sinai Cornell University The Royal Free Hospital University College London

About

Judilyn Fuentes‐Duculan is an author at Rockefeller University specializing in medicine, immunology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	40	8.9K
2	Allergy	6	6	1.3K
3	Cell Biology	5	5	408
4	Allergy Medicine	2	2	402
5	Health Sciences	1	1	184

Judilyn Fuentes‐Duculan

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells Michelle A. Lowes, Toyoko Kikuchi, Judilyn Fuentes‐Duculan, Journal of Investigative Dermatology Th17 T CellsAutoimmune DiseaseMedicineT-regulatory CellImmune Regulation	2008	1.1K
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis Julia Gittler, Avner Shemer, Mayte Suárez‐Fariñas, Journal of Allergy and Clinical Immunology InflammationProgressive ActivationAtopic DermatitisImmunologyTh2/th22 Cytokines	2012	931
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways Kristine Nograles, Lisa C. Zaba, Emma Guttman‐Yassky, British Journal of Dermatology	2008	795
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses Lisa C. Zaba, Irma Cardinale, Patricia Gilleaudeau, The Journal of Experimental Medicine T-regulatory CellImmunologyImmune RegulationImmunologic MechanismDermatology	2007	665
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells Kristine Nograles, Lisa C. Zaba, Avner Shemer, Journal of Allergy and Clinical Immunology InflammationAtopic DermatitisUpregulated Il-22ImmunologyT Cell Immunity	2009	606
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a) Michelle A. Lowes, Francesca Chamian, Maria Veronica Abello, Proceedings of the National Academy of Sciences Nitric OxideImmune RegulationImmunologyDermatologyImmunotherapy	2005	448
Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells Lisa C. Zaba, Judilyn Fuentes‐Duculan, Narat J. Eungdamrong, Journal of Investigative Dermatology InflammationCytokineAutoimmune DiseaseMedicineImmunology	2008	428
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial Emma Guttman‐Yassky, Patrick M. Brunner, Avidan U. Neumann, Journal of the American Academy of Dermatology	2018	328
Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis Emma Guttman‐Yassky, Michelle A. Lowes, Judilyn Fuentes‐Duculan, The Journal of Immunology ImmunologyImmune RegulationDermatologyImmunotherapyPsoriatic Arthritis	2008	322
Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis Mayte Suárez‐Fariñas, Katherine Li, Judilyn Fuentes‐Duculan, Journal of Investigative Dermatology	2012	302

Page 1